Cargando…
Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study
BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761625/ https://www.ncbi.nlm.nih.gov/pubmed/31364457 http://dx.doi.org/10.1161/JAHA.119.012776 |
_version_ | 1783454060588826624 |
---|---|
author | Yu, Yuan Spatz, Erica S. Tan, Qi Liu, Shuling Lu, Yuan Masoudi, Frederick A. Schulz, Wade L. Krumholz, Harlan M. Li, Jing |
author_facet | Yu, Yuan Spatz, Erica S. Tan, Qi Liu, Shuling Lu, Yuan Masoudi, Frederick A. Schulz, Wade L. Krumholz, Harlan M. Li, Jing |
author_sort | Yu, Yuan |
collection | PubMed |
description | BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample of Western medicine hospitals in China in 2015 using data from the China PEACE 5r‐HF (China Patient‐Centered Evaluative Assessment of Cardiac Events 5 Retrospective Heart Failure Study). We describe the frequency of TCM use and its association with patient characteristics, in‐hospital use of evidence‐based therapies, and hospital characteristics using hierarchical logistic regression models. Finally, we assessed risk‐adjusted in‐hospital bleeding and mortality. Among 10 004 patients hospitalized with HF (median age, 73 years; 48.9% women) from 189 hospitals, 74.7% received TCM (83.3% administered intravenously). The most commonly used agent was Salvia miltiorrhiza (51.2%). Patients with coronary artery disease (odds ratio [OR], 1.73; 95% CI, 1.53–1.95) or stroke (OR, 1.32; 95% CI, 1.15–1.51) were more likely to receive TCM; there was no correlation with evidence‐based therapy use. Nearly all hospitals (99.4%) used TCM, with substantial variation across hospitals (median OR, 3.29; 95% CI, 2.82–3.76). In‐patient bleeding (OR, 1.39; 95% CI, 1.03–1.88) and mortality (OR, 1.36; 95% CI, 1.04–1.79) were higher with Salvia miltiorrhiza, although not with other TCMs. CONCLUSIONS: In a nationally representative sample of patients hospitalized with acute HF in China, three fourths received TCM. Nearly all hospitals used TCM, although use varied substantially by hospital. Although TCM was not used in lieu of evidence‐based therapies for HF, we found a signal for harm with the most commonly used TCM. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02877914. |
format | Online Article Text |
id | pubmed-6761625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-67616252019-09-30 Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study Yu, Yuan Spatz, Erica S. Tan, Qi Liu, Shuling Lu, Yuan Masoudi, Frederick A. Schulz, Wade L. Krumholz, Harlan M. Li, Jing J Am Heart Assoc Original Research BACKGROUND: Traditional Chinese medicine (TCM) is used in the treatment of many conditions, including heart failure (HF), although it is not well characterized. METHODS AND RESULTS: We conducted a retrospective analysis of TCM use in a random sample of hospitalizations for HF within a random sample of Western medicine hospitals in China in 2015 using data from the China PEACE 5r‐HF (China Patient‐Centered Evaluative Assessment of Cardiac Events 5 Retrospective Heart Failure Study). We describe the frequency of TCM use and its association with patient characteristics, in‐hospital use of evidence‐based therapies, and hospital characteristics using hierarchical logistic regression models. Finally, we assessed risk‐adjusted in‐hospital bleeding and mortality. Among 10 004 patients hospitalized with HF (median age, 73 years; 48.9% women) from 189 hospitals, 74.7% received TCM (83.3% administered intravenously). The most commonly used agent was Salvia miltiorrhiza (51.2%). Patients with coronary artery disease (odds ratio [OR], 1.73; 95% CI, 1.53–1.95) or stroke (OR, 1.32; 95% CI, 1.15–1.51) were more likely to receive TCM; there was no correlation with evidence‐based therapy use. Nearly all hospitals (99.4%) used TCM, with substantial variation across hospitals (median OR, 3.29; 95% CI, 2.82–3.76). In‐patient bleeding (OR, 1.39; 95% CI, 1.03–1.88) and mortality (OR, 1.36; 95% CI, 1.04–1.79) were higher with Salvia miltiorrhiza, although not with other TCMs. CONCLUSIONS: In a nationally representative sample of patients hospitalized with acute HF in China, three fourths received TCM. Nearly all hospitals used TCM, although use varied substantially by hospital. Although TCM was not used in lieu of evidence‐based therapies for HF, we found a signal for harm with the most commonly used TCM. CLINICAL TRIAL REGISTRATION: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02877914. John Wiley and Sons Inc. 2019-07-31 /pmc/articles/PMC6761625/ /pubmed/31364457 http://dx.doi.org/10.1161/JAHA.119.012776 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Yu, Yuan Spatz, Erica S. Tan, Qi Liu, Shuling Lu, Yuan Masoudi, Frederick A. Schulz, Wade L. Krumholz, Harlan M. Li, Jing Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title | Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title_full | Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title_fullStr | Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title_full_unstemmed | Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title_short | Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China: Analysis From the China PEACE Retrospective Heart Failure Study |
title_sort | traditional chinese medicine use in the treatment of acute heart failure in western medicine hospitals in china: analysis from the china peace retrospective heart failure study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761625/ https://www.ncbi.nlm.nih.gov/pubmed/31364457 http://dx.doi.org/10.1161/JAHA.119.012776 |
work_keys_str_mv | AT yuyuan traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT spatzericas traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT tanqi traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT liushuling traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT luyuan traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT masoudifredericka traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT schulzwadel traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT krumholzharlanm traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT lijing traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy AT traditionalchinesemedicineuseinthetreatmentofacuteheartfailureinwesternmedicinehospitalsinchinaanalysisfromthechinapeaceretrospectiveheartfailurestudy |